Abstract
Background: Hypertension is a highly prevalent chronic disease worldwide and a major cardiovascular risk factor. Oleanolic acid (3β-hydroxy-olea-12-en-28-oic acid) is a widely distributed bioactive pentacyclic triterpenoid with diverse biological activities such as anti-inflammatory, hepaprotective, anti-diabetic or anti-hypertensive.
Objective: The aim of this study was to review and highlight the available data regarding the antihypertensive activity of oleanolic acid and the described mechanisms of action.
Methods: Extensive searches were made in the available literature on oleanolic acid and the data investigating its antihypertensive effects were analysed.
Results: Most of the research has been performed on animal models of hypertension, ex vivo studies with aortic ring and some in vitro tests with cell cultures, whereas clinical trials are still lacking. Treatment of hypertensive animals with oleanolic acid significantly ameliorated the rise in the systolic blood pressure. In addition, the hypotensive effects of oleanolic acid are also related to a potent diuretic-natriuretic activity and nephroprotection. In vitro studies have characterized the participation of various signalling pathways that modulate the release of vasodilation mediators.
Conclusion: In vitro and in vivo studies suggest that oleanolic acid effectively reduces blood pressure and could be an interesting co-adjuvant to conventional treatment of hypertension.
Keywords: Hypertension, cardiovascular risk, triterpenoid, vasodilation, blood pressure.
Current Molecular Pharmacology
Title:Hypotensive Effects of the Triterpene Oleanolic Acid for Cardiovascular Prevention
Volume: 14
Author(s): Antonio Sureda*, Magalida Monserrat-Mesquida, Samuel Pinya, Pere Ferriol and Silvia Tejada
Affiliation:
- Research Group on Community Nutrition and Oxidative Stress (NUCOX) and Health Research Institute of Balearic Islands (IdISBa), Department of Fundamental Biology and Health Sciences and CIBEROBN (Physiopathology of Obesity and Nutrition CB12/03/30038), University of the Balearic Islands, Palma, Illes Balears,Spain
Keywords: Hypertension, cardiovascular risk, triterpenoid, vasodilation, blood pressure.
Abstract:
Background: Hypertension is a highly prevalent chronic disease worldwide and a major cardiovascular risk factor. Oleanolic acid (3β-hydroxy-olea-12-en-28-oic acid) is a widely distributed bioactive pentacyclic triterpenoid with diverse biological activities such as anti-inflammatory, hepaprotective, anti-diabetic or anti-hypertensive.
Objective: The aim of this study was to review and highlight the available data regarding the antihypertensive activity of oleanolic acid and the described mechanisms of action.
Methods: Extensive searches were made in the available literature on oleanolic acid and the data investigating its antihypertensive effects were analysed.
Results: Most of the research has been performed on animal models of hypertension, ex vivo studies with aortic ring and some in vitro tests with cell cultures, whereas clinical trials are still lacking. Treatment of hypertensive animals with oleanolic acid significantly ameliorated the rise in the systolic blood pressure. In addition, the hypotensive effects of oleanolic acid are also related to a potent diuretic-natriuretic activity and nephroprotection. In vitro studies have characterized the participation of various signalling pathways that modulate the release of vasodilation mediators.
Conclusion: In vitro and in vivo studies suggest that oleanolic acid effectively reduces blood pressure and could be an interesting co-adjuvant to conventional treatment of hypertension.
Export Options
About this article
Cite this article as:
Sureda Antonio*, Monserrat-Mesquida Magalida, Pinya Samuel, Ferriol Pere and Tejada Silvia, Hypotensive Effects of the Triterpene Oleanolic Acid for Cardiovascular Prevention, Current Molecular Pharmacology 2021; 14 (6) : e301221189669 . https://dx.doi.org/10.2174/1874467213999201230211544
DOI https://dx.doi.org/10.2174/1874467213999201230211544 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
Call for Papers in Thematic Issues
Advances in the Diagnosis and Treatment of Head and Neck Disease
Head and neck diseases encompass a wide range of conditions affecting the oral cavity, pharynx, larynx, nasal passages, sinuses, salivary glands, and other structures of the head and neck region. These diseases can have significantly on essential function, such as breathing, swallowing, speaking, as well as the quality of life. ...read more
Common mechanisms underpinning neurodevelopmental disorders and psychiatric diseases
A growing number of large-scale epidemiologic studies has strongly suggested that common mechanisms may be shared by aberrant brain development and psychiatric disorders. There is now an appreciation of synergic roles of genetic variants and environmental stress which profoundly affect the genome integrity and reshape brain development. This can lead ...read more
Pharmacology and Toxicology of Plant Bioactive Compounds
The thematic issue "Pharmacology and Toxicology of Plant Bioactive Compounds" aims to explore the multifaceted aspects of bioactive compounds derived from plants, delving into their pharmacological properties and potential toxicological implications. This issue will encompass a wide array of research, including investigations into the therapeutic benefits of plant-derived compounds, such ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update
Current Pharmaceutical Design Ischemic Neuronal Damage
Current Pharmaceutical Design Orthostatic Hypotension: Evaluation and Treatment
Cardiovascular & Hematological Disorders-Drug Targets Mast Cells: Target and Source of Neuropeptides
Current Pharmaceutical Design Dual COX-Inhibitors: The Answer is NO?
Current Topics in Medicinal Chemistry Development of Small Molecule Non-peptide Formyl Peptide Receptor (FPR) Ligands and Molecular Modeling of Their Recognition
Current Medicinal Chemistry Pathophysiology of Sepsis and Recent Patents on the Diagnosis, Treatment and Prophylaxis for Sepsis
Recent Patents on Inflammation & Allergy Drug Discovery Cisternal Sustained Release Dihydropyridines for Subarachnoid Hemorrhage
Current Neurovascular Research Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Off-Label Trazodone Prescription: Evidence, Benefits and Risks
Current Pharmaceutical Design Engineered Inorganic/Organic-Core/Shell Magnetic Fe<sub>x</sub>O<sub>y</sub> Nanoparticles with Oleic Acid and/or Oleylamine As Capping Agents
Current Pharmaceutical Design Molecular Properties Prediction and Synthesis of Novel Pyrazoline Carboxamide Analogs as Antitubercular Agents
Anti-Infective Agents Radiolabeled Compounds in Diagnosis of Infectious and Inflammatory Disease
Current Pharmaceutical Design The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
Current Medicinal Chemistry Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice
Current Pharmaceutical Design A Comparative Effectiveness Systematic Review and Meta-analysis of Drugs for the Prophylaxis of Junctional Ectopic Tachycardia
Current Cardiology Reviews Subject Index to Volume 2
Current Vascular Pharmacology Cardiotoxicity of 5-Fluorouracil
Cardiovascular & Hematological Agents in Medicinal Chemistry Proteinase-Activated Receptor-2: Physiological and Pathophysiological Roles
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Modulation of Potassium Channels as a Therapeutic Approach
Current Pharmaceutical Design